Cell and gene therapies are redefining treatment possibilities, yet fragmented manufacturing processes, complex referral...
Start with the smallest story of the year, because it may turn out to be the most important. Until this summer, Mithril ...
--Charles River Laboratories’ third-quarter results offer CEO Birgit Girshick stronger evidence of impro...
As autoimmune and allergic diseases present increasingly complex diagnostic challenges, laboratories face growing pressu...
By Vincent Caradec, Co-Founder and CEO, Healthi Life Somewhere, this week, someone is booking a flight in the hope that...
Women's health remains one of healthcare's most significant unmet needs, despite advances in diagnostics, treatments and...
BIOPLUS-INTERPHEX KOREA 2026 closed at COEX on Friday with its shortest conference day and, in some ways, its most forwa...
Asia-Pacific carries a disproportionate burden of drug-resistant infections. The World Health Organization’s (WHO)...
In 2026, Novo Nordisk’s Awiqli became the first once-weekly basal insulin to receive approval from the US Food and...
Over the past few decades, Vietnam has transitioned to a dynamic, middle-income nation, achieving profound transformatio...
Asia Pacific is helping set the next milestone in global action on breast cancer. ASEAN’s latest decision to eleva...
The year is 2026. Artificial intelligence (AI) has moved from buzzword to backbone in healthcare. Across Asia, hospitals...
Regenerative medicine is entering a defining phase as stem-cell research moves beyond laboratory discoveries towards cli...
If Day 1 of BIX 2026 asked what makes a Korean asset partnerable, Day 2 asked what happens once someone wants it. Thursd...
Ask most investors to name South Korea's bio clusters and the list starts with Songdo, moves on to Pangyo and Osong, and...
Brain–computer interfaces (BCIs) are entering a new phase of technological development, moving beyond experimental...
Healthcare’s growing use of data is changing the expertise required to advance research and improve care. For exam...
The global antimicrobial resistance (AMR) research and development community came together in Portugal’s capital, ...
Revenue Grew 9% Including 6% Organic Revenue Growth Grew GAAP Diluted EPS 9% and Adjusted EPS 15% Outstanding perfor...
Healthcare is generating more data than ever, yet much of its potential remains locked within disconnected systems. As a...
Asia-Pacific stands at a defining moment in interventional cardiology, where technological advancement must be m...
Artificial intelligence is reshaping biologics development by enabling faster antibody selection, early identification o...
Clinical research has become increasingly global, yet an important distinction remains between conducting clinical trial...
China and India are contributing different strengths to Asia Pacific’s medical technology industry, from manufactu...
As laboratories across Asia-Pacific face growing demands for faster, more precise and reproducible analytical testing, F...
